E25.8
Other adrenogenital disorders
HCC risk adjustment mapping
CMS-HCC ESRD V24
Other Significant Endocrine and Metabolic Disorders
RxHCC V08
Pituitary, Adrenal Gland, and Other Endocrine and Metabolic Disorders
Coding notes
Excludes 1 never coded together · Excludes 2 may co-exist
code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
Idiopathic adrenogenital disorder
adrenogenital syndromes, virilizing or feminizing, whether acquired or due to adrenal hyperplasia consequent on inborn enzyme defects in hormone synthesis Female adrenal pseudohermaphroditism Female heterosexual precocious pseudopuberty Male isosexual precocious pseudopuberty Male macrogenitosomia praecox Male sexual precocity with adrenal hyperplasia Male virilization (female)
transitory endocrine and metabolic disorders specific to newborn (P70-P74)
All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
Official Guidelines for E25.8
FY 2026 ›Find E25.8 in the alphabetic index
11 index paths lead to this code
- Adrenogenital syndrome › acquired
- Pseudohermaphroditism › adrenal
- Pseudopuberty, precocious › female heterosexual
- Pseudopuberty, precocious › male isosexual
- Disorder › adrenogenital › drug-induced
- Disorder › adrenogenital › iatrogenic
- Disorder › adrenogenital › idiopathic
- Pseudohermaphroditism › female › with adrenocortical disorder
- Pseudohermaphroditism › male › adrenal
- Pseudohermaphroditism › male › with › adrenocortical disorder
- Puberty › premature › due to › adrenal cortical hyperfunction